Correction: Characterization of chitosan- and β-cyclodextrin-modified forms of magnesium-doped hydroxyapatites as enhanced carriers for levofloxacin: loading, release, and anti-inflammatory properties.

RSC Adv

Published: June 2024

The text indicates there is a correction to a previously published research article, identified by its Digital Object Identifier (DOI).
The DOI number 10.1039/D4RA02144D is likely referencing a specific article in scientific literature, which may have contained inaccuracies or errors that needed to be addressed.
The correction aims to clarify or amend the original findings to ensure accurate dissemination of information in the field.

[This corrects the article DOI: 10.1039/D4RA02144D.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155549	PMC
http://dx.doi.org/10.1039/d4ra90068e	DOI Listing

Publication Analysis

correction characterization

characterization chitosan-

chitosan- β-cyclodextrin-modified

β-cyclodextrin-modified forms

forms magnesium-doped

magnesium-doped hydroxyapatites

hydroxyapatites enhanced

enhanced carriers

carriers levofloxacin

levofloxacin loading

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!